Kiniksa Pharmaceuticals Ltd (KNSA)
20.33
+0.34
(+1.70%)
USD |
NASDAQ |
May 07, 16:00
20.33
0.00 (0.00%)
After-Hours: 18:51
Kiniksa Pharmaceuticals Max Drawdown (5Y): 83.06% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 83.06% |
March 31, 2024 | 83.06% |
February 29, 2024 | 83.06% |
January 31, 2024 | 83.06% |
December 31, 2023 | 83.06% |
November 30, 2023 | 83.06% |
October 31, 2023 | 83.06% |
September 30, 2023 | 83.06% |
August 31, 2023 | 83.06% |
July 31, 2023 | 83.06% |
June 30, 2023 | 83.06% |
May 31, 2023 | 83.06% |
April 30, 2023 | 83.06% |
March 31, 2023 | 83.06% |
February 28, 2023 | 83.06% |
January 31, 2023 | 83.06% |
December 31, 2022 | 83.06% |
November 30, 2022 | 83.06% |
October 31, 2022 | 83.06% |
September 30, 2022 | 83.06% |
August 31, 2022 | 83.06% |
July 31, 2022 | 83.06% |
June 30, 2022 | 83.06% |
May 31, 2022 | 83.06% |
April 30, 2022 | 83.06% |
Date | Value |
---|---|
March 31, 2022 | 83.06% |
February 28, 2022 | 83.06% |
January 31, 2022 | 83.06% |
December 31, 2021 | 83.06% |
November 30, 2021 | 83.06% |
October 31, 2021 | 83.06% |
September 30, 2021 | 83.06% |
August 31, 2021 | 83.06% |
July 31, 2021 | 83.06% |
June 30, 2021 | 83.06% |
May 31, 2021 | 83.06% |
April 30, 2021 | 83.06% |
March 31, 2021 | 83.06% |
February 28, 2021 | 83.06% |
January 31, 2021 | 83.06% |
December 31, 2020 | 83.06% |
November 30, 2020 | 83.06% |
October 31, 2020 | 83.06% |
September 30, 2020 | 83.06% |
August 31, 2020 | 83.06% |
July 31, 2020 | 83.06% |
June 30, 2020 | 83.06% |
May 31, 2020 | 83.06% |
April 30, 2020 | 83.06% |
March 31, 2020 | 83.06% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
53.70%
Minimum
May 2019
83.06%
Maximum
Oct 2019
81.44%
Average
83.06%
Median
Oct 2019
Max Drawdown (5Y) Benchmarks
Amicus Therapeutics Inc | 74.97% |
Geron Corp | 86.09% |
United Therapeutics Corp | 60.30% |
Vanda Pharmaceuticals Inc | 89.11% |
TG Therapeutics Inc | 93.19% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -1.023 |
Beta (5Y) | 0.3233 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 64.60% |
Historical Sharpe Ratio (5Y) | 0.0399 |
Historical Sortino (5Y) | 0.0895 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 23.55% |